Accelerate to Market Genetically Engineered, Off-the-Shelf and Cost Effective NK Cell Immunotherapies for Solid Tumor Indications

 The Innate Killer Summit 2019 discusses safer, more cost-effective and potentially more efficacious NK cell immunotherapy as the next generation of frontline cancer therapy.

It will help you to optimize your manufacturing and process development strategies to further reduce the cost of off-the-shelf NK cell therapies. Discuss the most up to date clinical data on genetically engineered NK cells from CARs to bispecific engagers and ensure persistence and durability.

Bringing together over 100 of the field’s leading minds to share experience and knowledge on the optimal NK cell source and improve the efficacy of NK cell therapies through enhanced targeting methods. Join us at the 4th Annual Innate Killer Summit to bring to patients the next generation of cell immunotherapies that are safer and cheaper.